• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN Back to Search Results
Model Number 04T7520
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/29/2021
Event Type  malfunction  
Event Description
The customer observed (b)(6) alinity i insulin results on a newborn baby.The initial result on (b)(6) 2021 for sid (b)(4) was (b)(6) uu/ml normal ((b)(6) to (b)(6) uu/ml), the second sample sid (b)(4) had an initial result of (b)(6) uu/ml, repeated (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) / (b)(6) uu/ml.No impact to patient management was reported.
 
Manufacturer Narrative
Patient identifier: sid sid (b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
The ticket search by lot indicates that the reagent lot perform as expected for this product.Return testing was not completed as returns were not available.Trending review did not identify any trends for the complaint issue.Device history record review did not identify any issues associated with lot 97511lp66 and the complaint issue.Accuracy testing was performed to evaluate the performance of reagent lot 97511lp66.An internal alinity i insulin panel was tested with retained kits of the likely cause reagent lot.Acceptance criteria was met, which indicates acceptable product performance.Labeling was reviewed and found to adequately address the issue of falsely elevated results.Based on the investigation, no systemic issue or deficiency of the alinity i insulin reagent lot 97511lp66 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I INSULIN REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
christian lee
100 abbott park road
dept. 09b9, lc cp01-3
abbott park, IL 60064-3537
2246682940
MDR Report Key12797438
MDR Text Key282918289
Report Number3002809144-2021-00646
Device Sequence Number1
Product Code CFP
UDI-Device Identifier00380740150815
UDI-Public00380740150815
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/08/2022
Device Model Number04T7520
Device Catalogue Number04T75-20
Device Lot Number97511LP66
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI01971; ALNTY I PROCESSING MODU, 03R65-01, AI01971
-
-